SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Excelsior Medical Aug revenue rises to NT$944.3M vs NT$714.1M

Excelsior Medical reported 2026 revenue of NT$944,347,000 versus NT$714,087,000 in 2025. Jan-Aug revenue was NT$6,516,641,000 versus NT$5,741,455,000, per Taiwan Stock Exchange data.

4104

Excelsior Medical Co. Ltd. reported revenue in New Taiwan dollars of NT$944,347,000 for 2026, compared with NT$714,087,000 a year earlier. Jan-Aug revenue was NT$6,516,641,000 in 2026 versus NT$5,741,455,000 in 2025.

Source: Taiwan Stock Exchange.